1. Home
  2. LEG vs IMCR Comparison

LEG vs IMCR Comparison

Compare LEG & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leggett & Platt Incorporated

LEG

Leggett & Platt Incorporated

HOLD

Current Price

$11.75

Market Cap

1.6B

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$33.19

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEG
IMCR
Founded
1883
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LEG
IMCR
Price
$11.75
$33.19
Analyst Decision
Hold
Buy
Analyst Count
4
11
Target Price
$10.50
$64.30
AVG Volume (30 Days)
1.4M
469.2K
Earning Date
02-12-2026
02-25-2026
Dividend Yield
1.68%
N/A
EPS Growth
N/A
N/A
EPS
1.61
N/A
Revenue
$4,172,899,999.00
$379,590,000.00
Revenue This Year
N/A
$32.42
Revenue Next Year
N/A
$11.17
P/E Ratio
$7.39
N/A
Revenue Growth
N/A
28.11
52 Week Low
$6.48
$23.15
52 Week High
$12.77
$40.72

Technical Indicators

Market Signals
Indicator
LEG
IMCR
Relative Strength Index (RSI) 49.36 41.51
Support Level $11.99 $34.34
Resistance Level $12.77 $35.89
Average True Range (ATR) 0.36 1.54
MACD -0.10 0.20
Stochastic Oscillator 10.09 31.02

Price Performance

Historical Comparison
LEG
IMCR

About LEG Leggett & Platt Incorporated

Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: